Dallas, TX, United States of America

Zerrin F Yetkin


Average Co-Inventor Count = 7.0

ph-index = 1

Forward Citations = 40(Granted Patents)


Company Filing History:


Years Active: 2002

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Zerrin F Yetkin: Innovator in Alzheimer's Disease Research

Introduction

Zerrin F Yetkin is a notable inventor based in Dallas, TX (US). He has made significant contributions to the field of medical imaging, particularly in the study of Alzheimer's disease. His innovative work has the potential to enhance the understanding and diagnosis of this complex condition.

Latest Patents

Zerrin F Yetkin holds a patent for an "MRI system and method for producing an index indicative of Alzheimer's disease." This patent describes a method where time course MRI data is acquired from the hippocampal region of the brain. The data is processed to produce an index that measures the functional connectivity between locations in the hippocampus. The MRI data is collected while the brain is at rest, and the spontaneous low-frequency component of the time course data is extracted and compared through a cross-correlation process. This innovative approach aims to improve the diagnostic capabilities for Alzheimer's disease.

Career Highlights

Zerrin F Yetkin is associated with the McW Research Foundation, Inc., where he continues to advance his research in medical imaging and Alzheimer's disease. His work is characterized by a commitment to developing technologies that can lead to better patient outcomes.

Collaborations

Zerrin has collaborated with esteemed colleagues such as Shi-Jiang Li and Piero Antuono. These partnerships have fostered a collaborative environment that enhances the research and development of innovative solutions in the medical field.

Conclusion

Zerrin F Yetkin's contributions to the field of Alzheimer's research through his patented MRI technology exemplify the impact of innovation in medicine. His work not only advances scientific understanding but also holds promise for improving diagnostic methods for Alzheimer's disease.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…